Article Versions Notes

Oudah KH, Najm MAA, Ramsis TM, Ebrahim MA, Gohar NA, Abu-Elfotuh K, Mohamed EK, Hamdan AME, Hamdan AM, Almotairi R, et al. Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer’s Disease: In Vivo, In Vitro, Histopathological, and Docking Studies. Pharmaceuticals. 2025; 18(8):1214. https://doi.org/10.3390/ph18081214

Oudah, Khulood H., Mazin A. A. Najm, Triveena M. Ramsis, Maha A. Ebrahim, Nirvana A. Gohar, Karema Abu-Elfotuh, Ehsan Khedre Mohamed, Ahmed M. E. Hamdan, Amira M. Hamdan, Reema Almotairi, and et al. 2025. "Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer’s Disease: In Vivo, In Vitro, Histopathological, and Docking Studies" Pharmaceuticals 18, no. 8: 1214. https://doi.org/10.3390/ph18081214

Oudah, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu-Elfotuh, K., Mohamed, E. K., Hamdan, A. M. E., Hamdan, A. M., Almotairi, R., Abdelmohsen, S. R., Abdelhakim, K. R., Elsharkawy, A. M. A., & Fayed, E. A. (2025). Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer’s Disease: In Vivo, In Vitro, Histopathological, and Docking Studies. Pharmaceuticals, 18(8), 1214. https://doi.org/10.3390/ph18081214